XS-04

· NovaOnco Therapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XS-04, covering 2025-03-04 to 2025-03-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of XS-04 in Patients with Relapsed or Refractory Hematologic Malignancies [Phase 1]